UB Paderborn / Katalog / Suche / in CDI

Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays

Journal of clinical virology, 2022-10, Vol.155, p.105269-105269, Article 105269

2022

Link zum Volltext

Verfügbarkeit prüfen

The Activation of Mucosal-Associated Invariant T (MAIT) Cells Is Affected by Microbial Diversity and Riboflavin Utilization in vitro

Frontiers in microbiology, 2020-04, Vol.11, p.755-755

2020

Link zum Volltext

Verfügbarkeit prüfen

Mucosal-associated invariant T-Cell (MAIT) activation is altered by chlorpyrifos- and glyphosate-treated commensal gut bacteria

Journal of immunotoxicology, 2020-01, Vol.17 (1), p.10-20

2020

Link zum Volltext

Verfügbarkeit prüfen

High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin

Journal of substance abuse treatment, 2010-06, Vol.38 (4), p.338-345

2010

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera

Journal of clinical virology plus, 2021-09, Vol.1 (3), p.100038-100038, Article 100038

2021

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of OPT-80 against Clostridium difficile

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2280-2282

2004

Link zum Volltext

Verfügbarkeit prüfen

OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review

Expert opinion on investigational drugs, 2008-04, Vol.17 (4), p.547-553

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparative In Vitro Activities of Gemifloxacin, Other Quinolones, and Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria

Antimicrobial Agents and Chemotherapy, 2001-06, Vol.45 (6), p.1896-1899

2001

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of the ermB Gene in Clostridium difficile Strains Isolated at a University Teaching Hospital from 1987 through 1998

Clinical infectious diseases, 2005-05, Vol.40 (10), p.1537-1540

2005

Link zum Volltext

Verfügbarkeit prüfen

Drugs of the 21st century: telithromycin (HMR 3647)—the first ketolide

Journal of antimicrobial chemotherapy, 2003-03, Vol.51 (3), p.497-511

2003

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activities of Gatifloxacin, Two Other Quinolones, and Five Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria

Antimicrobial Agents and Chemotherapy, 1999-11, Vol.43 (11), p.2783-2786

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile

Journal of medical microbiology, 2008-06, Vol.57 (6), p.776-783

2008

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile

Diagnostic microbiology and infectious disease, 2007-09, Vol.59 (1), p.1-5

2007

Link zum Volltext

Verfügbarkeit prüfen

Resistance to Moxifloxacin in ToxigenicClostridium difficile Isolates Is Associated with Mutations in gyrA

Antimicrobial Agents and Chemotherapy, 2001-08, Vol.45 (8), p.2348-2353

2001

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea

Journal of medical microbiology, 2005-02, Vol.54 (2), p.149-153

2005

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and association of macrolide–lincosamide– streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile

Journal of antimicrobial chemotherapy, 2003-03, Vol.51 (3), p.599-603

2003

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of linezolid against Clostridium difficile

Journal of antimicrobial chemotherapy, 2003-03, Vol.51 (3), p.743-745

2003

Link zum Volltext

Verfügbarkeit prüfen

Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA

Antimicrobial agents and chemotherapy, 2001-08, Vol.45 (8), p.2348-2353

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli

Journal of antimicrobial chemotherapy, 2004-02, Vol.53 (2), p.318-324

2004

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Linezolid against Clostridium difficile

Antimicrobial Agents and Chemotherapy, 2002-05, Vol.46 (5), p.1617-1618

2002

Link zum Volltext

Verfügbarkeit prüfen

In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria

International journal of antimicrobial agents, 2000-11, Vol.16 (3), p.225-232

2000

Link zum Volltext

Verfügbarkeit prüfen

Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea

Diagnostic microbiology and infectious disease, 2001-07, Vol.40 (3), p.103-106

2001

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of sitafloxacin against Clostridium difficile

Journal of antimicrobial chemotherapy, 2001-05, Vol.47 (5), p.722-724

2001

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic efficacy of moxifloxacin in a murine model of severe systemic mixed infection with Escherichia coli and Bacteroides fragilis

Anaerobe, 2003-08, Vol.9 (4), p.157-160

2003

Link zum Volltext

Verfügbarkeit prüfen

Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies

Journal of medical virology, 1998-08, Vol.55 (4), p.281-287

1998

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays

The Activation of Mucosal-Associated Invariant T (MAIT) Cells Is Affected by Microbial Diversity and Riboflavin Utilization in vitro

Mucosal-associated invariant T-Cell (MAIT) activation is altered by chlorpyrifos- and glyphosate-treated commensal gut bacteria

High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera

In Vitro Activity of OPT-80 against Clostridium difficile

OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review

Comparative In Vitro Activities of Gemifloxacin, Other Quinolones, and Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria

Prevalence of the ermB Gene in Clostridium difficile Strains Isolated at a University Teaching Hospital from 1987 through 1998

Drugs of the 21st century: telithromycin (HMR 3647)—the first ketolide

In Vitro Activities of Gatifloxacin, Two Other Quinolones, and Five Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria

Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile

Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile

Resistance to Moxifloxacin in ToxigenicClostridium difficile Isolates Is Associated with Mutations in gyrA

Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea

Prevalence and association of macrolide–lincosamide– streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile

In vitro activity of linezolid against Clostridium difficile

Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA

Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli

In Vitro Activity of Linezolid against Clostridium difficile

In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria

Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea

In vitro activity of sitafloxacin against Clostridium difficile

Therapeutic efficacy of moxifloxacin in a murine model of severe systemic mixed infection with Escherichia coli and Bacteroides fragilis

Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies

Suchergebnisse filtern